Investigating the Utility of the BrainEye Smartphone Eye Tracking Application and Platform in Concussion Management.

Sports Med Open

Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia.

Published: March 2025

Background: Concussion is a common consequence of engaging in collision sports, with the often mild, transient nature of symptoms posing a considerable diagnostic and management challenge. This challenge is vastly magnified for athletes competing at grassroots/non-professional levels, who lack field side access to medical expertise in the assessment of a player's capacity to continue playing or need for further medical attention. The aim of this pilot study was to evaluate the utility of the BrainEye application and hardware (BrainEye platform) as a concussion screening tool, specifically determining (1) its sensitivity and specificity with respect to identifying an individual with a clinically diagnosed concussion, (2) the stability of the platform through test completion/failure rates, and (3) its usability through operator feedback and uptake/integration into concussion management protocols.

Results: Using the BrainEye platform, 348 male professional Australian Rules footballers from 10 Australian Football League (AFL) clubs completed 4 simple ocular protocols (pupillary light reflex, PLR; smooth pursuit eye movements, SMP; near-point convergence, NPC; horizontal gaze nystagmus, HGN) at baseline, prior to the onset of the 2022 AFL season, and following the clinical diagnosis of concussion throughout the season during a game/training/practice (n = 11 players immediately following a concussive event, and on 14 occasions 2-7 days following a concussive event). Although club participation and protocol adherence rates were suboptimal, with clubs citing COVID-19 restrictions and cumbersome hardware set-up as primary reasons for non-participation/missing data, a BrainEye score that derived from an algorithm combining smooth pursuit and pupillary light reflex measures, achieved 100% sensitivity relative to clinical judgement, in identifying all instances of clinically diagnosed concussion, and 85% specificity.

Conclusions: Collectively, the results of this study suggest that by removing the requirement for add-on hardware and providing a smartphone-only option with direct feedback on performance to the user, the BrainEye application may provide a useful screening tool for sport-related concussion.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40798-025-00819-8DOI Listing

Publication Analysis

Top Keywords

utility braineye
8
concussion
8
platform concussion
8
concussion management
8
braineye application
8
braineye platform
8
screening tool
8
clinically diagnosed
8
diagnosed concussion
8
pupillary light
8

Similar Publications

Background: Concussion is a common consequence of engaging in collision sports, with the often mild, transient nature of symptoms posing a considerable diagnostic and management challenge. This challenge is vastly magnified for athletes competing at grassroots/non-professional levels, who lack field side access to medical expertise in the assessment of a player's capacity to continue playing or need for further medical attention. The aim of this pilot study was to evaluate the utility of the BrainEye application and hardware (BrainEye platform) as a concussion screening tool, specifically determining (1) its sensitivity and specificity with respect to identifying an individual with a clinically diagnosed concussion, (2) the stability of the platform through test completion/failure rates, and (3) its usability through operator feedback and uptake/integration into concussion management protocols.

View Article and Find Full Text PDF

Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

J Clin Oncol

September 2020

Division of Blood and Marrow Transplantation, Children's National Health System, Washington, DC.

Purpose: The Children's Oncology Group (COG) protocol AALL0434 evaluated the safety and efficacy of multi-agent chemotherapy with Capizzi-based methotrexate/pegaspargase (C-MTX) in patients with newly diagnosed pediatric T-cell lymphoblastic lymphoma (T-LL) and gained preliminary data using nelarabine in high-risk patients.

Patients And Methods: The trial enrolled 299 patients, age 1-31 years. High-risk (HR) patients had ≥ 1% minimal detectable disease (MDD) in the bone marrow at diagnosis or received prior steroid treatment.

View Article and Find Full Text PDF

Congenital esotropia and amblyopia are treated during the 'sensitive period' of brain-eye development. Not all children require spectacles for treatment of these conditions but when refractive errors are present, correct and properly fitting spectacles play an important part. This prospective survey shows that one-third of the under three-year-old children wearing spectacles require surgery for esotropia, and that one-third of all children under eight years of age wearing spectacles need amblyopia treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!